|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.240
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.186
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.184
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.180
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.178
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.174
|
Mouse |
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.174
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.174
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.171
|
Mouse |
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.159
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.159
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.155
|
Mouse |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.154
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.147
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.147
|
Mouse |
|
|
t cell activation
|
GO:0042110 |
289 |
0.146
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.136
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.128
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.127
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.125
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.112
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.109
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.107
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.105
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.104
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.101
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.101
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.099
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.095
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.094
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.088
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.087
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.087
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.086
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.079
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.078
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.077
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.077
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.076
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.074
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.072
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.070
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.068
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.068
|
Mouse |
|
|
appendage development
|
GO:0048736 |
166 |
0.067
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.066
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.065
|
|
|
|
fast calcium ion dependent exocytosis of neurotransmitter
|
GO:0098746 |
1 |
0.065
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.063
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.062
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.062
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.062
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.061
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.061
|
Mouse |
|
|
membrane depolarization
|
GO:0051899 |
64 |
0.061
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.061
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.060
|
Mouse |
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.060
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.060
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.060
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.060
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.060
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.060
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.059
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.059
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.059
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.059
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.057
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.056
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.056
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.055
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.054
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.054
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.054
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.053
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.053
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.053
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.052
|
Mouse |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.052
|
|
|
|
dendritic spine development
|
GO:0060996 |
30 |
0.052
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.051
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.049
|
|
|
|
cellular amide metabolic process
|
GO:0043603 |
58 |
0.049
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.049
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.049
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.049
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.049
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.049
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.048
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.048
|
Mouse |
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.048
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.048
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.048
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.048
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.048
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.048
|
|
|
|
planar cell polarity pathway involved in neural tube closure
|
GO:0090179 |
14 |
0.047
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.047
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.047
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.046
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.046
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.046
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.046
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.046
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.046
|
Mouse |
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.046
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.045
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.045
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.045
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.044
|
|
|
|
establishment of protein localization to vacuole
|
GO:0072666 |
4 |
0.044
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.043
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.043
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.042
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.042
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.041
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
62 |
0.041
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.041
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.041
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.041
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.041
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.041
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.041
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.040
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.040
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.040
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
18 |
0.040
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.040
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.040
|
Mouse |
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.040
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.039
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.039
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.039
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.039
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.038
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.038
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.038
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.038
|
|
|
|
ventral spinal cord interneuron fate commitment
|
GO:0060579 |
14 |
0.038
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.038
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.038
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.038
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.037
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.037
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.037
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.037
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.037
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.037
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.037
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.037
|
Mouse |
|
|
inflammatory response
|
GO:0006954 |
244 |
0.037
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.037
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.036
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.036
|
|
|
|
maintenance of presynaptic active zone structure
|
GO:0048790 |
1 |
0.036
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.036
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.036
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.036
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.036
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.035
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.035
|
|
|
|
regulation of establishment of planar polarity
|
GO:0090175 |
28 |
0.035
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.035
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.035
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.035
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.035
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.035
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.035
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.035
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.034
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.034
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.034
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.034
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.034
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.034
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.034
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.033
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.033
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.033
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.033
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.033
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.033
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.033
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.033
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.033
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.032
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.032
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.032
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.032
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.032
|
|
|
|
negative regulation of smoothened signaling pathway
|
GO:0045879 |
25 |
0.032
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.031
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.031
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.031
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.031
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.031
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.030
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.030
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.030
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.030
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.030
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.030
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.030
|
|
|
|
olfactory bulb interneuron development
|
GO:0021891 |
7 |
0.030
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.030
|
|
|
|
non canonical wnt signaling pathway
|
GO:0035567 |
33 |
0.030
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.030
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.030
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.029
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.029
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.029
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.029
|
|
|
|
glutamate receptor signaling pathway
|
GO:0007215 |
35 |
0.029
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.028
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.028
|
|
|
|
positive regulation of antimicrobial peptide biosynthetic process
|
GO:0002807 |
1 |
0.028
|
|
|
|
positive regulation of antimicrobial peptide production
|
GO:0002225 |
1 |
0.028
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.028
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.028
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.028
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.028
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.028
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.028
|
Mouse |
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.027
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.027
|
|
|
|
inner ear receptor cell differentiation
|
GO:0060113 |
61 |
0.027
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.027
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.027
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.027
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in spinal cord motor neuron fate specification
|
GO:0021912 |
3 |
0.027
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.027
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.027
|
|
|
|
negative regulation of dendritic spine morphogenesis
|
GO:0061002 |
3 |
0.027
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.027
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.027
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.026
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
19 |
0.026
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.026
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
27 |
0.026
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.026
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.026
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.026
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.025
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.025
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.025
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.025
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.025
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.025
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.025
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
40 |
0.025
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.025
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.025
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.025
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.025
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.025
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.025
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.025
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.024
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.024
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.024
|
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.024
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.024
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.024
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.024
|
|
|
|
central nervous system segmentation
|
GO:0035283 |
3 |
0.024
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.024
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.024
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.024
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.024
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.024
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.023
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.023
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.023
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.023
|
|
|
|
regulation of glutamate receptor signaling pathway
|
GO:1900449 |
16 |
0.023
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.023
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.023
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.023
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.023
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.023
|
Mouse |
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.023
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.023
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
48 |
0.023
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.023
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.023
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.023
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.023
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
35 |
0.023
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.023
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.023
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.023
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.023
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.023
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.023
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.022
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.022
|
|
|
|
olfactory bulb development
|
GO:0021772 |
30 |
0.022
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.022
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.022
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.022
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.022
|
|
|
|
regulation of alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor activity
|
GO:2000311 |
11 |
0.022
|
|
|
|
insulin processing
|
GO:0030070 |
2 |
0.022
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.022
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.022
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.022
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.022
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.022
|
Mouse |
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.022
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.022
|
|
|
|
olfactory bulb interneuron differentiation
|
GO:0021889 |
12 |
0.021
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.021
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.021
|
|
|
|
cerebellar granular layer development
|
GO:0021681 |
13 |
0.021
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.021
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.021
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.021
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.021
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.021
|
|
|
|
cell differentiation in hindbrain
|
GO:0021533 |
24 |
0.021
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.021
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.021
|
Mouse |
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.021
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.021
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.020
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.020
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.020
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.020
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.020
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.020
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.020
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.020
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.020
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.020
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.020
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.020
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.020
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.020
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.020
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.020
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.019
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.019
|
Mouse |
|
|
regulation of dendritic spine development
|
GO:0060998 |
22 |
0.019
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.019
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.019
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.019
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.019
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.019
|
|
|
|
learning
|
GO:0007612 |
98 |
0.019
|
|
|
|
motor neuron migration
|
GO:0097475 |
4 |
0.019
|
|
|
|
positive regulation of sodium ion transmembrane transport
|
GO:1902307 |
4 |
0.018
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.018
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.018
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.018
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.018
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.018
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.018
|
|
|
|
positive regulation of synaptic plasticity
|
GO:0031915 |
4 |
0.018
|
|
|
|
negative regulation of catenin import into nucleus
|
GO:0035414 |
2 |
0.018
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.018
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.018
|
Mouse |
|
|
auditory receptor cell fate determination
|
GO:0042668 |
3 |
0.018
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.018
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.018
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.018
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.018
|
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.018
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.018
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.018
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.018
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.018
|
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.018
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.018
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.018
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.018
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.018
|
|
|
|
negative regulation of adenylate cyclase activity
|
GO:0007194 |
1 |
0.018
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.018
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.018
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.018
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.018
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.018
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.018
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.017
|
|
|
|
ectodermal cell fate commitment
|
GO:0001712 |
1 |
0.017
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.017
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.017
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.017
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.017
|
|
|
|
regulation of phosphatidylcholine biosynthetic process
|
GO:2001245 |
2 |
0.017
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.017
|
Mouse |
|
|
pancreatic pp cell differentiation
|
GO:0003312 |
2 |
0.017
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.017
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in ventral spinal cord interneuron specification
|
GO:0021913 |
4 |
0.017
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.017
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.017
|
|
|
|
negative regulation of dendritic spine development
|
GO:0061000 |
3 |
0.017
|
|
|
|
positive regulation of neuron projection regeneration
|
GO:0070572 |
2 |
0.017
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.017
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.017
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.017
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.017
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.017
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.017
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.017
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.017
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.017
|
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.017
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.017
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.016
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.016
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.016
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.016
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.016
|
|
|
|
regulation of production of molecular mediator of immune response
|
GO:0002700 |
65 |
0.016
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.016
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.016
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.016
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.016
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.016
|
|
|
|
positive regulation of semaphorin plexin signaling pathway
|
GO:2001262 |
1 |
0.016
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.016
|
|
|
|
inner cell mass cell fate commitment
|
GO:0001827 |
2 |
0.016
|
|
|
|
macula densa development
|
GO:0072024 |
1 |
0.016
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.016
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.016
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.016
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.016
|
|
|
|
ventral spinal cord interneuron differentiation
|
GO:0021514 |
16 |
0.016
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.016
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.016
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.016
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.016
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.016
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.016
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.016
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.016
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.016
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.016
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.015
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.015
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.015
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.015
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.015
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.015
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.015
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.015
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.015
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.015
|
|
|
|
negative regulation of mechanoreceptor differentiation
|
GO:0045632 |
3 |
0.015
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.015
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.015
|
|
|
|
cochlea development
|
GO:0090102 |
35 |
0.015
|
|
|
|
regulation of auditory receptor cell differentiation
|
GO:0045607 |
4 |
0.015
|
|
|
|
hypothalamus cell differentiation
|
GO:0021979 |
8 |
0.015
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.015
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.015
|
|
|
|
postsynaptic membrane organization
|
GO:0001941 |
18 |
0.015
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.015
|
|
|
|
establishment of neuroblast polarity
|
GO:0045200 |
1 |
0.014
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.014
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.014
|
|
|
|
mrna transcription from rna polymerase ii promoter
|
GO:0042789 |
4 |
0.014
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.014
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.014
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.014
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.014
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.014
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.014
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.014
|
|
|
|
ventricular compact myocardium morphogenesis
|
GO:0003223 |
2 |
0.014
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.014
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.014
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.014
|
Mouse |
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.014
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.014
|
Mouse |
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.014
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.014
|
|
|
|
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:2000800 |
1 |
0.014
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.014
|
|
|
|
prepulse inhibition
|
GO:0060134 |
10 |
0.014
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.014
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.014
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.014
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.014
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.014
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.014
|
|
|
|
antimicrobial peptide biosynthetic process
|
GO:0002777 |
2 |
0.014
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.014
|
|
|
|
negative chemotaxis
|
GO:0050919 |
14 |
0.014
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.014
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.014
|
|
|
|
mitral valve development
|
GO:0003174 |
4 |
0.014
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.014
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.014
|
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.014
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.014
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.013
|
|
